Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dependence

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...

CNS Depressants: Alcohol and Nicotine

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...

Stimulants

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Stress Prevention and Stress Management Techniques IV

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The impact of tax policies on living organ donations in the United States.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012

Same author

The global tobacco disease pandemic: nature, causes, and cures.

Global public health·2009

Same author

The US tobacco control community's view of the future of tobacco harm reduction.

Tobacco control·2003

Same author

Innovative approaches to youth tobacco control: introduction and overview.

Tobacco control·2003

Same author

Smoking on the rise among young adults: implications for research and policy.

Tobacco control·2003

Same author

Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines.

Tissue antigens·2002

Search research articles

Related Experiment Video

Updated: Jul 20, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

Tobacco harm reduction: what do the experts think?

E G Martin¹, K E Warner, P M Lantz

¹Department of Health Management & Policy, School of Public Health, University of Michigan, 109 South Observatory, Road, Ann Arbor, Michigan, 48109-2029, USA.

Tobacco Control

|June 4, 2004

Summary

Experts believe tobacco harm reduction (THR) is plausible and requires regulation, but face challenges due to stakeholder mistrust and a lack of consensus on specifics for these novel nicotine products.

More Related Videos

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

Related Experiment Videos

Last Updated: Jul 20, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

Area of Science:

Public Health
Tobacco Control
Nicotine Science

Background:

Novel nicotine products offer potential for tobacco harm reduction (THR).
Assessing expert opinions is crucial for navigating the future of THR.
Understanding challenges to THR implementation is vital for public health.

Purpose of the Study:

To gauge expert perspectives on the future of tobacco harm reduction (THR).
To explore the potential of novel nicotine products in improving public health.
To identify expert opinions on the feasibility and regulation of THR.

Main Methods:

Semi-structured telephone interviews were conducted with 29 professionals.
Qualitative content analysis was applied to coded interview transcripts.
Participants included tobacco control advocates, industry scientists, non-industry scientists, and Congressional staff.

Main Results:

Experts agreed THR is theoretically plausible and that "good" and "bad" products can be identified.
There was consensus on the essential need for government regulation, though its near-term likelihood was doubted.
Significant disagreement existed on specific regulatory strategies and ideal THR products, with pervasive mistrust among stakeholders.
Mistrust between groups like tobacco control advocates and industry scientists was a cited barrier.

Conclusions:

Continued dialogue is essential in the evolving landscape of products claiming to reduce tobacco-related harm.
Effective government regulation is deemed crucial for minimizing THR risks and maximizing benefits.
Addressing stakeholder mistrust is key to advancing THR initiatives and public health goals.